Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226466 · ClinicalTrials.gov registry record
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
A clinical trial, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- 40
- Enrollment target
NCT07226466: Clinical Trial study, sponsored by University of California, San Francisco.
NCT07226466 is a clinical trial that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07226466 has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study investigates the effects of brain radiotherapy on cognitive function by evaluating plasma biomarkers and apolipoprotein E (APOE) genotype in patients with primary or metastatic brain tumors. Standard brain radiotherapy is known to impact cognitive outcomes, yet the underlying biological mechanisms remain unclear.
Primary Outcome
Mean change in biomarker for Aβ over time will be reported
Interventions
- PROCEDURE Blood sample
- PROCEDURE Brain magnetic resonance imaging (MRI)
- PROCEDURE Brain Health Assessment
- RADIATION Quality of Life (QoL) Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-10-31 |
What is known before NCT07226466 opens enrollment
NCT07226466 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Blood sample is the first listed.
NCT07226466 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07226466 about?
NCT07226466 is a clinical study titled "Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer". This study investigates the effects of brain radiotherapy on cognitive function by evaluating plasma biomarkers and apolipoprotein E (APOE) genotype in patients with primary or metastatic brain tumors. Standard brain radiotherapy is known to impact cognitive outcomes, yet the underlying biological m...
What is the current status of trial NCT07226466?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-07-01. Estimated completion is 2028-10-31.
What interventions are being tested in trial NCT07226466?
The interventions under investigation include: Blood sample (PROCEDURE), Brain magnetic resonance imaging (MRI) (PROCEDURE), Brain Health Assessment (PROCEDURE), Quality of Life (QoL) Questionnaire (RADIATION).
Who is sponsoring clinical trial NCT07226466?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI